FDA Panel Recommends 2 RSV Vaccines for Older Adults
After hours of deliberation over safety concerns, a Food and Drug Administration advisory panel on Wednesday recommended approval of a second vaccine for the respiratory syncytial virus in older adults, advancing the first shots against an illness that can be deadly for the very young and the very old. Over two days this week, the…
Details